🇫🇷 BNT162b7 Bivalent (Original/OMI BA.4/BA.5) in France

BNT162b7 Bivalent (Original/OMI BA.4/BA.5) (bnt162b7-bivalent-original-omi-ba-4-ba-5) regulatory status in France.

Marketing authorisation

ANSM

  • Status: approved

BNT162b7 Bivalent (Original/OMI BA.4/BA.5) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in France

Frequently asked questions

Is BNT162b7 Bivalent (Original/OMI BA.4/BA.5) approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for BNT162b7 Bivalent (Original/OMI BA.4/BA.5) in France?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.